Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Clinical Features of Myositis: Muscular Manifestation

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F20%3AN0000012" target="_blank" >RIV/00023728:_____/20:N0000012 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://link-springer-com.ezproxy.is.cuni.cz/chapter/10.1007/978-3-030-15820-0_5" target="_blank" >https://link-springer-com.ezproxy.is.cuni.cz/chapter/10.1007/978-3-030-15820-0_5</a>

  • DOI - Digital Object Identifier

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Clinical Features of Myositis: Muscular Manifestation

  • Popis výsledku v původním jazyce

    The main muscular symptom of inflammatory myopathies is muscle weakness. It is mostly symmetrical and proximally located in patients with polymyositis (PM), dermatomyositis (DM), and immune mediated necrotising myopathy (IMNM). In IBM it is usually asymmetric and more often distal. In amyopathic DM weakness may not be present or clinically obvious and sometimes can only be found when tested for. Muscle pain may be present, but not as a main symptom, and if predominant, it should raise suspicion for other diagnosis. Muscular weakness is usually caused by disease activity, but also acquired muscle damage or drug-induced myopathy could be the reason. Dysphagia is a frequent symptom and is due to active inflammation of upper esophagus muscles. Treatment-resistant dysphagia may be the consequence of muscle fibrosis. MRI is a useful technique to visualize inflammation, which manifests as edema on MR images. Atrophy, fibrosis, and fatty infiltration can also be observed. A number of conditions may mimic inflammatory myopathy. The presence of ocular or facial muscle involvement, scapular winging, second-wind phenomenon, prominent distal weakness, exercise-induced cramps, fasting-associated symptoms, fasciculations, myotonia, and dominant pain but also nonresponse to treatment, absence of myositis autoantibodies, lack of any extramuscular symptoms, and possibly also history of the use of myopathic drugs should lead to suspicion of neuropathy, muscle dystrophy, metabolic myopathy, endocrinopathy, toxic myopathy, or fibromyalgia.

  • Název v anglickém jazyce

    Clinical Features of Myositis: Muscular Manifestation

  • Popis výsledku anglicky

    The main muscular symptom of inflammatory myopathies is muscle weakness. It is mostly symmetrical and proximally located in patients with polymyositis (PM), dermatomyositis (DM), and immune mediated necrotising myopathy (IMNM). In IBM it is usually asymmetric and more often distal. In amyopathic DM weakness may not be present or clinically obvious and sometimes can only be found when tested for. Muscle pain may be present, but not as a main symptom, and if predominant, it should raise suspicion for other diagnosis. Muscular weakness is usually caused by disease activity, but also acquired muscle damage or drug-induced myopathy could be the reason. Dysphagia is a frequent symptom and is due to active inflammation of upper esophagus muscles. Treatment-resistant dysphagia may be the consequence of muscle fibrosis. MRI is a useful technique to visualize inflammation, which manifests as edema on MR images. Atrophy, fibrosis, and fatty infiltration can also be observed. A number of conditions may mimic inflammatory myopathy. The presence of ocular or facial muscle involvement, scapular winging, second-wind phenomenon, prominent distal weakness, exercise-induced cramps, fasting-associated symptoms, fasciculations, myotonia, and dominant pain but also nonresponse to treatment, absence of myositis autoantibodies, lack of any extramuscular symptoms, and possibly also history of the use of myopathic drugs should lead to suspicion of neuropathy, muscle dystrophy, metabolic myopathy, endocrinopathy, toxic myopathy, or fibromyalgia.

Klasifikace

  • Druh

    C - Kapitola v odborné knize

  • CEP obor

  • OECD FORD obor

    30226 - Rheumatology

Návaznosti výsledku

  • Projekt

  • Návaznosti

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Ostatní

  • Rok uplatnění

    2020

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název knihy nebo sborníku

    Managing Myositis: A Practical Guide

  • ISBN

    978-3-030-15819-4

  • Počet stran výsledku

    10

  • Strana od-do

    37-46

  • Počet stran knihy

    364

  • Název nakladatele

    Springer

  • Místo vydání

    Cham

  • Kód UT WoS kapitoly